Wren Laboratories
Wren Laboratories leverages the power of messenger RNA (mRNA) through advanced, minimally invasive liquid biopsy diagnostics. Our breakthrough technology goes beyond traditional gene mutation detection by providing critical insights into mRNA activity—the dynamic that links genome abnormalities with disease behavior. Wren Laboratories’ proprietary RNA stabilization and testing platform enables a clearer, more functional view of tumor biology. RNA profiling detects aberrations in signaling pathways, the drivers of tumor behavior. These actionable insights empower drug development teams and cancer care providers to make more informed decisions, enabling improved therapeutic choices and more precisely targeted interventions. Our technology also serves biopharma beyond biomarkers to include bioanalysis of the RNA drug molecules for PK/PD.
